header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

Trauma

COMBINED BONY AND SOFT-TISSUE STABILIZATION OF THE HIP IN CONGENITAL FEMORAL DEFICIENCY

British Limb Reconstruction Society (BLRS) Annual Conference, Southampton, March 2018



Abstract

Introduction

Aim of this study was to review a single surgeon series and analyse the results of hip reconstruction and compare them to an historical cohort.

Methods and results

Retrospective review from a prospective database was undertaken of 113 CFD children since 1999. 31 of these patients had hip reconstruction with combined soft tissue and bony procedures akin to the Superhip. This cohort was compared to the results of the previous series using deformity planning methods on radiographic imaging, quantification of acetabular and femoral geometry, focussing upon the effects and results of hip reconstruction and lengthening. Compared to the previous series, this cohort achieved greater objective increases in length and significantly fewer complications involving the hip joint during the process.11 hips out of 45 (24.4%) that were treated in the previous cohort subluxed during lengthening. Since 1999 there were no subluxations with improved hip geometry. Primary difference between the cohorts was the recent group's preparatory hip surgery before the commencement of any lengthening even for borderline dysplasias. This had not been the case for all children in the previous cohort. This indicates a steep learning curve in the last 3 decades concerning the importance of primary hip reconstruction as a preparatory stage of treatment before lengthening in CFD with almost normalised acetabulae.

Conclusion

Management of CFD needs detailed and methodical planning of soft tissue and bony deformities and better understanding has evolved over time to provide improved results and outcomes.

Level of evidence

Therapeutic III


Email: